The DOI matches its Crossref record; 78 of the 78 references it cites were found in a registry or an index.
Gut symbionts alleviate MASH through a secondary bile acid biosynthetic pathway
Open accessAbstract
The gut microbiota has been found to play an important role in the progression of metabolic dysfunction-associated steatohepatitis (MASH), but the mechanisms have not been established. Here, by developing a click-chemistry-based enrichment strategy, we identified several microbial-derived bile acids, including the previously uncharacterized 3-succinylated cholic acid (3-sucCA), which is negatively correlated with liver damage in patients with liver-tissue-biopsy-proven metabolic dysfunction-associated fatty liver disease (MAFLD). By screening human bacterial isolates, we identified Bacteroides uniformis strains as effective producers of 3-sucCA both in vitro and in vivo. By activity-based protein purification and identification, we identified an enzyme annotated as β-lactamase in B. uniformis responsible for 3-sucCA biosynthesis. Furthermore, we found that 3-sucCA is a lumen-restricted metabolite and alleviates MASH by promoting the growth of Akkermansia muciniphila. Together, our data offer new insights into the gut microbiota-liver axis that may be leveraged to augment the management of MASH.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Fast gapped-read alignment with Bowtie 2
Langmead, B., & Salzberg, S. L. (2012) · Nature Methods · doi:10.1038/nmeth.1923 · Cited by 56,400
IQ-TREE: A Fast and Effective Stochastic Algorithm for Estimating Maximum-Likelihood Phylogenies
Nguyen, L.-T., Schmidt, H. A., von Haeseler, A., & Minh, B. Q. (2015) · Molecular Biology and Evolution · doi:10.1093/molbev/msu300 · Cited by 26,046
Metagenomic biomarker discovery and explanation
Segata, N., Izard, J., Waldron, L., Gevers, D., Miropolsky, L., Garrett, W. S., & Huttenhower, C. (2011) · Genome Biology · doi:10.1186/gb-2011-12-6-r60 · Cited by 16,192
Interactive Tree Of Life (iTOL) v5: an online tool for phylogenetic tree display and annotation
Letunic, I., & Bork, P. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkab301 · Cited by 11,124
Design and validation of a histological scoring system for nonalcoholic fatty liver disease†
Kleiner, D. E., Brunt, E. M., Van Natta, M., Behling, C., Contos, M. J., Cummings, O. W., Ferrell, L. D., Liu, Y., Torbenson, M. S., Unalp‐Arida, A., et al. (2005) · Hepatology · doi:10.1002/hep.20701 · Cited by 10,791
Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity
Everard, A., Belzer, C., Geurts, L., Ouwerkerk, J. P., Druart, C., Bindels, L. B., Guiot, Y., Derrien, M., Muccioli, G. G., Delzenne, N. M., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1219451110 · Cited by 4,511
Mechanisms of NAFLD development and therapeutic strategies
Friedman, S. L., Neuschwander-Tetri, B. A., Rinella, M., & Sanyal, A. J. (2018) · Nature Medicine · doi:10.1038/s41591-018-0104-9 · Cited by 4,354
MAFLD: a consensus-driven proposed nomenclature for metabolic associated fatty liver disease
Eslam, M., Sanyal, A. J., George, J., Sanyal, A., Neuschwander-Tetri, B., Tiribelli, C., Kleiner, D. E., Brunt, E., Bugianesi, E., Yki-Järvinen, H., et al. (2020) · Gastroenterology · doi:10.1053/j.gastro.2019.11.312 · Cited by 3,286
Non-alcoholic fatty liver disease
Powell, E. E., Wong, V. W.-S., & Rinella, M. (2021) · The Lancet · doi:10.1016/s0140-6736(20)32511-3 · Cited by 2,789
Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity
Henao-Mejia, J., Elinav, E., Jin, C., Hao, L., Mehal, W. Z., Strowig, T., Thaiss, C. A., Kau, A. L., Eisenbarth, S. C., Jurczak, M. J., et al. (2012) · Nature · doi:10.1038/nature10809 · Cited by 2,435
Depommier, C., Everard, A., Druart, C., Plovier, H., Van Hul, M., Vieira-Silva, S., Falony, G., Raes, J., Maiter, D., Delzenne, N. M., et al. (2019) · Nature Medicine · doi:10.1038/s41591-019-0495-2 · Cited by 2,357
Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome
Yoshimoto, S., Loo, T. M., Atarashi, K., Kanda, H., Sato, S., Oyadomari, S., Iwakura, Y., Oshima, K., Morita, H., Hattori, M., et al. (2013) · Nature · doi:10.1038/nature12347 · Cited by 2,219
Plovier, H., Everard, A., Druart, C., Depommier, C., Van Hul, M., Geurts, L., Chilloux, J., Ottman, N., Duparc, T., Lichtenstein, L., et al. (2017) · Nature Medicine · doi:10.1038/nm.4236 · Cited by 2,204
MetaPhlAn2 for enhanced metagenomic taxonomic profiling
Truong, D. T., Franzosa, E. A., Tickle, T. L., Scholz, M., Weingart, G., Pasolli, E., Tett, A., Huttenhower, C., & Segata, N. (2015) · Nature Methods · doi:10.1038/nmeth.3589 · Cited by 2,185
Mechanisms and disease consequences of nonalcoholic fatty liver disease
Loomba, R., Friedman, S. L., & Shulman, G. I. (2021) · Cell · doi:10.1016/j.cell.2021.04.015 · Cited by 2,002
Extensive impact of non-antibiotic drugs on human gut bacteria
Maier, L., Pruteanu, M., Kuhn, M., Zeller, G., Telzerow, A., Anderson, E. E., Brochado, A. R., Fernandez, K. C., Dose, H., Mori, H., et al. (2018) · Nature · doi:10.1038/nature25979 · Cited by 1,905
Precision microbiome reconstitution restores bile acid mediated resistance to Clostridium difficile
Buffie, C. G., Bucci, V., Stein, R. R., McKenney, P. T., Ling, L., Gobourne, A., No, D., Liu, H., Kinnebrew, M., Viale, A., et al. (2015) · Nature · doi:10.1038/nature13828 · Cited by 1,872
Self-citationShin, N.-R., Lee, J.-C., Lee, H.-Y., Kim, M.-S., Whon, T. W., Lee, M.-S., & Bae, J.-W. (2014) · Gut · doi:10.1136/gutjnl-2012-303839 · Cited by 1,550
Akkermansia muciniphila: paradigm for next-generation beneficial microorganisms
Cani, P. D., Depommier, C., Derrien, M., Everard, A., & de Vos, W. M. (2022) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-022-00631-9 · Cited by 1,192
Regulation of antibacterial defense in the small intestine by the nuclear bile acid receptor
Inagaki, T., Moschetta, A., Lee, Y.-K., Peng, L., Zhao, G., Downes, M., Yu, R. T., Shelton, J. M., Richardson, J. A., Repa, J. J., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0509592103 · Cited by 1,164
Anhê, F. F., Roy, D., Pilon, G., Dudonné, S., Matamoros, S., Varin, T. V., Garofalo, C., Moine, Q., Desjardins, Y., Levy, E., et al. (2015) · Gut · doi:10.1136/gutjnl-2014-307142 · Cited by 1,137
Gut microbiota–bile acid–interleukin-22 axis orchestrates polycystic ovary syndrome
Qi, X., Yun, C., Sun, L., Xia, J., Wu, Q., Wang, Y., Wang, L., Zhang, Y., Liang, X., Wang, L., et al. (2019) · Nature Medicine · doi:10.1038/s41591-019-0509-0 · Cited by 846
Self-citationGut microbiota-derived bile acids in intestinal immunity, inflammation, and tumorigenesis
Cai, J., Sun, L., & Gonzalez, F. J. (2022) · Cell Host & Microbe · doi:10.1016/j.chom.2022.02.004 · Cited by 843
Self-citationAdvancing the global public health agenda for NAFLD: a consensus statement
Lazarus, J. V., Mark, H. E., Anstee, Q. M., Arab, J. P., Batterham, R. L., Castera, L., Cortez-Pinto, H., Crespo, J., Cusi, K., Dirac, M. A., et al. (2022) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-021-00523-4 · Cited by 757
Self-citationJiao, N., Baker, S. S., Chapa-Rodriguez, A., Liu, W., Nugent, C. A., Tsompana, M., Mastrandrea, L., Buck, M. J., Baker, R. D., Genco, R. J., et al. (2018) · Gut · doi:10.1136/gutjnl-2017-314307 · Cited by 737
Novel bile acid biosynthetic pathways are enriched in the microbiome of centenarians
Sato, Y., Atarashi, K., Plichta, D. R., Arai, Y., Sasajima, S., Kearney, S. M., Suda, W., Takeshita, K., Sasaki, T., Okamoto, S., et al. (2021) · Nature · doi:10.1038/s41586-021-03832-5 · Cited by 632
Recovery of ethanol-induced Akkermansia muciniphila depletion ameliorates alcoholic liver disease
Grander, C., Adolph, T. E., Wieser, V., Lowe, P., Wrzosek, L., Gyongyosi, B., Ward, D. V., Grabherr, F., Gerner, R. R., Pfister, A., et al. (2018) · Gut · doi:10.1136/gutjnl-2016-313432 · Cited by 618
Molecular pathways of nonalcoholic fatty liver disease development and progression
Bessone, F., Razori, M. V., & Roma, M. G. (2019) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-018-2947-0 · Cited by 610
Human gut bacteria produce ΤΗ17-modulating bile acid metabolites
Paik, D., Yao, L., Zhang, Y., Bae, S., D’Agostino, G. D., Zhang, M., Kim, E., Franzosa, E. A., Avila-Pacheco, J., Bisanz, J. E., et al. (2022) · Nature · doi:10.1038/s41586-022-04480-z · Cited by 594
A metabolic pathway for bile acid dehydroxylation by the gut microbiome
Funabashi, M., Grove, T. L., Wang, M., Varma, Y., McFadden, M. E., Brown, L. C., Guo, C., Higginbottom, S., Almo, S. C., & Fischbach, M. A. (2020) · Nature · doi:10.1038/s41586-020-2396-4 · Cited by 590
Self-citationInteraction of gut microbiota with bile acid metabolism and its influence on disease states
Staley, C., Weingarden, A. R., Khoruts, A., & Sadowsky, M. J. (2017) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-016-8006-6 · Cited by 581
Global chemical effects of the microbiome include new bile-acid conjugations
Quinn, R. A., Melnik, A. V., Vrbanac, A., Fu, T., Patras, K. A., Christy, M. P., Bodai, Z., Belda-Ferre, P., Tripathi, A., Chung, L. K., et al. (2020) · Nature · doi:10.1038/s41586-020-2047-9 · Cited by 579
Non-alcoholic fatty liver disease: the interplay between metabolism, microbes and immunity
Tilg, H., Adolph, T. E., Dudek, M., & Knolle, P. (2021) · Nature Metabolism · doi:10.1038/s42255-021-00501-9 · Cited by 507
Profiling the human intestinal environment under physiological conditions
Shalon, D., Culver, R. N., Grembi, J. A., Folz, J., Treit, P. V., Shi, H., Rosenberger, F. A., Dethlefsen, L., Meng, X., Yaffe, E., et al. (2023) · Nature · doi:10.1038/s41586-023-05989-7 · Cited by 484
Metabolomics and lipidomics in NAFLD: biomarkers and non-invasive diagnostic tests
Masoodi, M., Gastaldelli, A., Hyötyläinen, T., Arretxe, E., Alonso, C., Gaggini, M., Brosnan, J., Anstee, Q. M., Millet, O., Ortiz, P., et al. (2021) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-021-00502-9 · Cited by 451
The role of farnesoid X receptor in metabolic diseases, and gastrointestinal and liver cancer
Sun, L., Cai, J., & Gonzalez, F. J. (2021) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-020-00404-2 · Cited by 435
Self-citationPuri, P., Daita, K., Joyce, A., Mirshahi, F., Santhekadur, P. K., Cazanave, S., Luketic, V. A., Siddiqui, M. S., Boyett, S., Min, H., et al. (2018) · Hepatology · doi:10.1002/hep.29359 · Cited by 426
Ha, C. W. Y., Martin, A., Sepich-Poore, G. D., Shi, B., Wang, Y., Gouin, K., Humphrey, G., Sanders, K., Ratnayake, Y., Chan, K. S. L., et al. (2020) · Cell · doi:10.1016/j.cell.2020.09.009 · Cited by 410
bioBakery: a meta’omic analysis environment
McIver, L. J., Abu-Ali, G., Franzosa, E. A., Schwager, R., Morgan, X. C., Waldron, L., Segata, N., & Huttenhower, C. (2018) · Bioinformatics · doi:10.1093/bioinformatics/btx754 · Cited by 361
Rao, Y., Kuang, Z., Li, C., Guo, S., Xu, Y., Zhao, D., Hu, Y., Song, B., Jiang, Z., Ge, Z., et al. (2021) · Gut Microbes · doi:10.1080/19490976.2021.1927633 · Cited by 356
Role of gut microbiota and Toll-like receptors in nonalcoholic fatty liver disease
Miura, K. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i23.7381 · Cited by 355
Challenges and opportunities in NASH drug development
Harrison, S. A., Allen, A. M., Dubourg, J., Noureddin, M., & Alkhouri, N. (2023) · Nature Medicine · doi:10.1038/s41591-023-02242-6 · Cited by 353
Altered Bile Acid Metabolome in Patients with Nonalcoholic Steatohepatitis
Ferslew, B. C., Xie, G., Johnston, C. K., Su, M., Stewart, P. W., Jia, W., Brouwer, K. L. R., & Sidney Barritt, A. (2015) · Digestive Diseases and Sciences · doi:10.1007/s10620-015-3776-8 · Cited by 335
Bile Acids Are Substrates for Amine N-Acyl Transferase Activity by Bile Salt Hydrolase
Patterson, A., Rimal, B., Collins, S., Granda, M., Koo, I., Solanka, S., Hoque, N., Gentry, E., Yan, T., Bisanz, J., et al. (2022) · doi:10.21203/rs.3.rs-2050120/v1 · Cited by 252
Metabolic Messengers: bile acids
Perino, A., & Schoonjans, K. (2022) · Nature Metabolism · doi:10.1038/s42255-022-00559-z · Cited by 223
Gut bacteria alleviate smoking-related NASH by degrading gut nicotine
Chen, B., Sun, L., Zeng, G., Shen, Z., Wang, K., Yin, L., Xu, F., Wang, P., Ding, Y., Nie, Q., et al. (2022) · Nature · doi:10.1038/s41586-022-05299-4 · Cited by 214
Self-citationYe, D., Li, F. Y. L., Lam, K. S. L., Li, H., Jia, W., Wang, Y., Man, K., Lo, C. M., Li, X., & Xu, A. (2012) · Gut · doi:10.1136/gutjnl-2011-300269 · Cited by 206
Sun, L., Pang, Y., Wang, X., Wu, Q., Liu, H., Liu, B., Liu, G., Ye, M., Kong, W., & Jiang, C. (2019) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2019.02.004 · Cited by 204
Self-citationEnlightening the taxonomy darkness of human gut microbiomes with a cultured biobank
Liu, C., Du, M.-X., Abuduaini, R., Yu, H.-Y., Li, D.-H., Wang, Y.-J., Zhou, N., Jiang, M.-Z., Niu, P.-X., Han, S.-S., et al. (2021) · Microbiome · doi:10.1186/s40168-021-01064-3 · Cited by 204
Self-citationA researcher’s guide to preclinical mouse NASH models
Gallage, S., Avila, J. E. B., Ramadori, P., Focaccia, E., Rahbari, M., Ali, A., Malek, N. P., Anstee, Q. M., & Heikenwalder, M. (2022) · Nature Metabolism · doi:10.1038/s42255-022-00700-y · Cited by 203
Kim, S., Lee, Y., Kim, Y., Seo, Y., Lee, H., Ha, J., Lee, J., Choi, Y., Oh, H., & Yoon, Y. (2020) · Applied and Environmental Microbiology · doi:10.1128/aem.03004-19 · Cited by 198
Wu, Q., Liang, X., Wang, K., Lin, J., Wang, X., Wang, P., Zhang, Y., Nie, Q., Liu, H., Zhang, Z., et al. (2021) · Cell Metabolism · doi:10.1016/j.cmet.2021.07.007 · Cited by 198
Self-citationDorrestein, P., Gentry, E., Collins, S., Panitchpakdi, M., Belda-Ferre, P., Stewart, A., Wang, M., Jarmusch, A., Avila-Pacheco, J., Plichta, D., et al. (2021) · doi:10.21203/rs.3.rs-820302/v1 · Cited by 197
Negi, C. K., Babica, P., Bajard, L., Bienertova-Vasku, J., & Tarantino, G. (2022) · Metabolism · doi:10.1016/j.metabol.2021.154925 · Cited by 190
Bile salt hydrolase/aminoacyltransferase shapes the microbiome
Guzior, D., Okros, M., Hernandez, C. M., Shivel, M., Armwald, B., Hausinger, R., & Quinn, R. (2022) · doi:10.21203/rs.3.rs-2050406/v1 · Cited by 187
Foley, M. H., Walker, M. E., Stewart, A. K., O’Flaherty, S., Gentry, E. C., Patel, S., Beaty, V. V., Allen, G., Pan, M., Simpson, J. B., et al. (2023) · Nature Microbiology · doi:10.1038/s41564-023-01337-7 · Cited by 181
Lucas, L. N., Barrett, K., Kerby, R. L., Zhang, Q., Cattaneo, L. E., Stevenson, D., Rey, F. E., & Amador-Noguez, D. (2021) · mSystems · doi:10.1128/msystems.00805-21 · Cited by 168
Juárez‐Fernández, M., Porras, D., Petrov, P., Román-Sagüillo, S., García‐Mediavilla, M. V., Soluyanova, P., Martínez‐Flórez, S., González‐Gallego, J., Nistal, E., Jover, R., et al. (2021) · Antioxidants · doi:10.3390/antiox10122001 · Cited by 142
microbeMASST: a taxonomically informed mass spectrometry search tool for microbial metabolomics data
Zuffa, S., Schmid, R., Bauermeister, A., Gomes, P. W. P., Caraballo‐Rodríguez, A. M., Abiead, Y. E., Aron, A. T., Gentry, E. C., Zemlin, J., Meehan, M. J., et al. (2024) · Nature Microbiology · doi:10.1038/s41564-023-01575-9 · Cited by 140
Gut commensal Christensenella minuta modulates host metabolism via acylated secondary bile acids
Liu, C., Du, M., Xie, L., Wang, W.-Z., Chen, B., Yun, C., Sun, X., Luo, X., Jiang, Y., Wang, K., et al. (2024) · Nature Microbiology · doi:10.1038/s41564-023-01570-0 · Cited by 135
Self-citationAranda-Díaz, A., Ng, K. M., Thomsen, T., Real-Ramírez, I., Dahan, D., Dittmar, S., Gonzalez, C. G., Chavez, T. M., Vasquez, K. S., Nguyen, T. H., et al. (2022) · Cell Host & Microbe · doi:10.1016/j.chom.2021.12.008 · Cited by 126
Han, Y., Ling, Q., Wu, L. M., Wang, X., Wang, Z., Chen, J., Zheng, Z., Zhou, Z., Jia, L., Li, L., et al. (2023) · Gut Microbes · doi:10.1080/19490976.2023.2221485 · Cited by 113
Chávez‐Talavera, O., Haas, J. T., Grzych, G., Tailleux, A., & Staels, B. (2019) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000597 · Cited by 87
Li, Z., Zhang, B., Wang, N., Zuo, Z., Hong Kui, W. E. I., & Zhao, F. (2022) · Gut · doi:10.1136/gutjnl-2022-328035 · Cited by 86
Model‐driven design of a minimal medium for Akkermansia muciniphila confirms mucus adaptation
van der Ark, K. C. H., Aalvink, S., Diez, M. S., Schaap, P. J., de Vos, W. M., & Belzer, C. (2018) · Microbial Biotechnology · doi:10.1111/1751-7915.13033 · Cited by 82
CRISPR/Cas-Based Genome Editing for Human Gut Commensal Bacteroides Species
Zheng, L., Tan, Y., Hu, Y., Shen, J., Qu, Z., Chen, X., Ho, C. L., Leung, E. L., Zhao, W., & Dai, L. (2022) · ACS Synthetic Biology · doi:10.1021/acssynbio.1c00543 · Cited by 82
DT-109 ameliorates nonalcoholic steatohepatitis in nonhuman primates
Qu, P., Rom, O., Li, K., Jia, L., Gao, X., Liu, Z., Ding, S., Zhao, M., Wang, H., Chen, S., et al. (2023) · Cell Metabolism · doi:10.1016/j.cmet.2023.03.013 · Cited by 81
Self-citationShi, Z., Lei, H., Chen, G., Yuan, P., Cao, Z., Ser, H.-L., Zhu, X., Wu, F., Liu, C., Dong, M., et al. (2021) · mSystems · doi:10.1128/msystems.00985-20 · Cited by 71
Ribó, S., Sánchez‐Infantes, D., Martínez-Guinó, L., García‐Mantrana, I., Ramon‐Krauel, M., Tondo, M., Arning, E., Nofrarías, M., Osorio-Conles, Ó., Fernández-Pérez, A., et al. (2021) · Science Translational Medicine · doi:10.1126/scitranslmed.abb0322 · Cited by 61
Production of New Microbially Conjugated Bile Acids by Human Gut Microbiota
García, C. J., Kosek, V., Beltrán, D., Tomás-Barberán, F. A., & Hajšlová, J. (2022) · Biomolecules · doi:10.3390/biom12050687 · Cited by 57
Hagi, T., Geerlings, S. Y., Nijsse, B., & Belzer, C. (2020) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-020-10976-3 · Cited by 56
Han, Y., Li, L., & Wang, B. (2022) · Frontiers of Medicine · doi:10.1007/s11684-022-0960-z · Cited by 44
Deep Interrogation of Metabolism Using a Pathway-Targeted Click-Chemistry Approach
Hoki, J. S., Le, H. H., Mellott, K. E., Zhang, Y. K., Fox, B. W., Rodrigues, P. R., Yu, Y., Helf, M. J., Baccile, J. A., & Schroeder, F. C. (2020) · Journal of the American Chemical Society · doi:10.1021/jacs.0c06877 · Cited by 38
Zhou, Y., Gao, F., Liu, W., Wong, G. L., Mahadeva, S., Mustapha, N. R. N., Wang, X., Chan, W., Wong, V. W., & Zheng, M. (2021) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.16487 · Cited by 34
Self-citationTakei, H., Narushima, S., Suzuki, M., Kakiyama, G., Sasaki, T., Murai, T., Yamashiro, Y., & Nittono, H. (2022) · Journal of Lipid Research · doi:10.1016/j.jlr.2022.100275 · Cited by 31
Decoding the microbiome: advances in genetic manipulation for gut bacteria
Chen, Z., Jin, W., Hoover, A., Chao, Y., & Ma, Y. (2023) · Trends in Microbiology · doi:10.1016/j.tim.2023.05.007 · Cited by 31
Microbially catalyzed conjugation of GABA and tyramine to bile acids
Mullowney, M. W., Fiebig, A., Schnizlein, M. K., McMillin, M., Rose, A. R., Koval, J., Rubin, D. T., Dalal, S. R., Sogin, M. L., Chang, E. B., et al. (2024) · Journal of Bacteriology · doi:10.1128/jb.00426-23 · Cited by 21
Structural Basis of Specificity for Carboxyl-Terminated Acyl Donors in a Bacterial Acyltransferase
Xiao, F., Dong, S., Liu, Y., Feng, Y., Li, H., Yun, C., Cui, Q., & Li, W. (2020) · Journal of the American Chemical Society · doi:10.1021/jacs.0c07331 · Cited by 13
Cited by
What defines a healthy gut microbiome?
Van Hul, M., Cani, P. D., Petitfils, C., De Vos, W. M., Tilg, H., & El-Omar, E. M. (2024) · Gut · doi:10.1136/gutjnl-2024-333378 · Cited by 369
Gut Microbiota Dysbiosis: Pathogenesis, Diseases, Prevention, and Therapy
Shen, Y., Fan, N., Ma, S., Cheng, X., Yang, X., & Wang, G. (2025) · MedComm · doi:10.1002/mco2.70168 · Cited by 301
Xu, X., Li, H., Lin, H., Li, Q., Liu, Y., Huang, W., Yang, J., Li, N., Gao, Z., Wang, S., et al. (2026) · Hepatology · doi:10.1097/hep.0000000000001429 · Cited by 16
Bile resistance mechanisms in probiotics: From structural adaptation to metabolic regulation
Hu, J.-W., Guo, S.-J., Zhang, L.-W., & Guo, C.-F. (2026) · Food Bioscience · doi:10.1016/j.fbio.2026.108282 · Cited by 5
Self-citation
Metadata
- Authors
- Nie, Q., Luo, X., Wang, K., Ding, Y., Jia, S., Zhao, Q., Li, M., Zhang, J., Zhuo, Y., Lin, J., Guo, C., Zhang, Z., Liu, H., Zeng, G., You, J., Sun, L., Lu, H., Ma, M., Jia, Y., Zheng, M.-H., Pang, Y., Qiao, J., & Jiang, C.
- Venue
- Cell
- Publisher
- Elsevier BV
- Published
- 2024-05
- Volume
- 187
- Issue
- 11
- Pages
- 2717-2734.e33
- ISSN
- 0092-8674 (ISSN-L)
- OpenAlex
- W4394998618
- Cited by
- 326
- References
- 78
- FWCI
- 37.88
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.